Mr. Toshitaka Hirano | Malignancy | Best Researcher Award

Posted on by Pencis

Mr. Toshitaka Hirano | Malignancy | Best Researcher Award

Pfizer Japan Inc | Japan

AUTHOR PROFILE

ORCID ID

🏫 EARLY ACADEMIC PURSUITS

Mr. Toshitaka Hirano pursued his education in Japan, specializing in fields related to oncology and pharmaceutical sciences. His early academic years were marked by a strong commitment to understanding the mechanisms of malignancy and its risk factors, laying the foundation for his influential career.

💼 PROFESSIONAL ENDEAVORS

Currently associated with Pfizer, Mr. Hirano has established himself as a leading expert in the risk factor analysis of malignancy. His role includes conducting advanced research, collaborating with global teams, and integrating pharmaceutical innovation with clinical practice.

🧬 CONTRIBUTIONS AND RESEARCH FOCUS

Mr. Hirano’s research is focused on identifying malignancy risk factors, particularly in patients with chronic conditions like rheumatoid arthritis. His studies examine the interplay between biological, environmental, and genetic factors contributing to cancer development. He has significantly advanced understanding in areas such as:

  • Immunogenicity risk associated with biologics
  • Cardiovascular events in rheumatic disease patients
  • Safety and effectiveness of novel therapies like tofacitinib

🌏 IMPACT AND INFLUENCE

Mr. Hirano’s work has had a profound impact on both clinical and research landscapes:

  • Policy and Practice: His findings inform public health guidelines and pharmaceutical strategies.
  • Patient Outcomes: Through his research, he has contributed to safer and more effective treatments for vulnerable populations.
  • International Collaboration: His global outreach ensures the dissemination of knowledge and best practices.

📚 ACADEMIC CITES

Mr. Hirano’s scholarly work is widely cited in high-impact journals, demonstrating its relevance and importance. Key publications include articles in International Journal of Rheumatic Diseases, Frontiers in Immunology, and Modern Rheumatology, highlighting his expertise in malignancy risk within rheumatic populations.

🏆 LEGACY AND FUTURE CONTRIBUTIONS ON MALIGNANCY

As a trailblazer in the field, Mr. Hirano is building a legacy of innovation and dedication to improving cancer outcomes. His future efforts aim to:

  • Develop predictive models for malignancy risks.
  • Enhance personalized medicine approaches.
  • Mentor the next generation of researchers in oncology and pharmaceutical sciences.

📌 OTHER IMPORTANT TOPICS

🔍 INTERDISCIPLINARY INTEGRATION

Mr. Hirano’s work bridges multiple fields, including oncology, immunology, and rheumatology, showcasing the value of a holistic research approach.

🌟 MENTORSHIP AND TEAM LEADERSHIP

He plays an active role in guiding young researchers and fostering collaborative environments that drive innovation.

🔔 PATIENT-CENTERED FOCUS

By emphasizing real-world data and patient-centered outcomes, Mr. Hirano ensures his work directly benefits those in need.

✨ CONCLUSION

Mr. Toshitaka Hirano’s dedication to malignancy risk analysis exemplifies the power of focused research to drive meaningful change. His work at Pfizer and beyond demonstrates a commitment to innovation, collaboration, and improving global health. With a legacy rooted in impactful research and a vision for a healthier future, Mr. Hirano continues to inspire and lead in the fight against cancer.

📊🔬NOTABLE PUBLICATION:
  • 1️⃣ Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real-World Setting in Japan
    • Authors: Kunihiro Yamaoka, Sugiyama N, Hoshi M, Jo JY, Kichul Shin, Hirano T
    • Journal: International Journal of Rheumatic Diseases
    • Year: 2024

    2️⃣ Individual and Population-Level Variability in HLA-DR Associated Immunogenicity Risk of Biologics Used for the Treatment of Rheumatoid Arthritis

    • Authors: Sugiyama N, Terry FE, Gutierrez AH, Hirano T, Hoshi M, Mizuno Y, Martin W, Yasunaga S, Niiro H, Fujio K, et al.
    • Journal: Frontiers in Immunology
    • Year: 2024

    3️⃣ Six-Month Safety and Effectiveness of Tofacitinib in Patients With Rheumatoid Arthritis in Japan: Interim Analysis of Post-Marketing Surveillance

    • Authors: Masataka Kuwana, Sugiyama N, Momohara S, Atsumi T, Takei S, Naoto Tamura, Masayoshi Harigai, Fujii T, Matsuno H, Takeuchi T, et al.
    • Journal: Modern Rheumatology
    • Year: 2024

Prof. Long Yang | Immunology | Best Researcher Award

Posted on by Pencis

Prof. Long Yang | Immunology | Best Researcher Award

Tianjin University of Traditional Chinese Medicine | China

AUTHOR PROFILE

Scopus

ORCID ID

LONG YANG, MD & PhD

🎓 EDUCATION

  • Doctor of Philosophy (PhD), Division of Experimental Medicine, Faculty of Medicine, McGill University, Canada (2005–2009)
  • Master of Medicine, Division of Pathology and Pathophysiology, Dalian Medical University, China (2000–2003)
  • Bachelor of Medicine (MD), Division of Clinical Medicine, Dalian Medical University, China (1989–1994)

🏢 EARLY ACADEMIC PURSUITS

Long Yang embarked on a robust academic journey with a foundational education in clinical medicine, followed by a specialization in pathology and pathophysiology. His PhD from McGill University further honed his expertise in experimental medicine, marking the start of an illustrious research career.

💼 PROFESSIONAL ENDEAVORS

  • Professor (2021–Present)
    Institute of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, China.
    Focused on advancing integrative medicine through innovative research and teaching.
  • Research Associate (2018–2020)
    Lady Davis Institute, Jewish General Hospital, McGill University, Canada.
    Contributed to cutting-edge research in cellular and molecular medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Yang’s research interests lie at the intersection of integrative medicine and experimental cellular mechanisms. He has contributed significantly to understanding infectious diseases and cellular pathophysiology. His work bridges traditional Chinese medicine and contemporary medical research, fostering novel therapeutic strategies.

🌟 IMPACT AND INFLUENCE

Dr. Yang’s tenure in academia and research institutions has been marked by:

  • Publication of numerous peer-reviewed articles in high-impact journals.
  • Development of interdisciplinary approaches combining traditional medicine and modern science.
  • Recognition as a thought leader in cellular and infection microbiology.

📚 ACADEMIC CITATIONS

His research has earned widespread recognition, with citations underscoring the global relevance of his contributions to experimental medicine and integrative healthcare solutions.

🔗 PROFESSIONAL SERVICE

  • Associate Editor, Frontiers in Cellular and Infection Microbiology.
    Played a pivotal role in curating impactful content, ensuring scientific rigor, and promoting advancements in the field.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Long Yang’s work continues to shape the integration of traditional and modern medical paradigms. His dedication to mentoring emerging scholars and contributing to healthcare innovations ensures a lasting legacy in both academia and clinical applications.

🌟CONCLUSION 🌿

Dr. Long Yang’s distinguished career as a researcher, educator, and practitioner showcases his unwavering dedication to advancing medicine through innovation and collaboration. By integrating traditional Chinese medicine with modern scientific methodologies, he has made a profound impact on healthcare, bridging cultural and academic divides.

📊🔬NOTABLE PUBLICATION:
  • The Gamble Between Oncolytic Virus Therapy and IFN
    • Authors: Li, Q., Tan, F., Wang, Y., Yang, L., Cen, S.
    • Journal: Frontiers in Immunology
    • Year: 2022

 

  • Repurposing of HIV/HCV Protease Inhibitors Against SARS-CoV-2 3CLpro
    • Authors: Ma, L., Li, Q., Xie, Y., Yang, L., Cen, S.
    • Journal: Antiviral Research
    • Year: 2022

 

  • SERINC5 Restricts Influenza Virus Infectivity
    • Authors: Zhao, F., Xu, F., Liu, X., Liang, C., Guo, F.
    • Journal: PLoS Pathogens
    • Year: 2022

 

  • COVID-19 Pandemic: A Multidisciplinary Perspective on the Pathogenesis of a Novel Coronavirus from Infection, Immunity and Pathological Responses
    • Authors: Yi, J., Miao, J., Zuo, Q., Kong, X., Yang, L.
    • Journal: Frontiers in Immunology
    • Year: 2022

 

  • Interferon-Inducible SAMHD1 Restricts Viral Replication Through Downregulation of Lipid Synthesis
    • Authors: An, N., Ge, Q., Shao, H., Yang, L., Cen, S.
    • Journal: Frontiers in Immunology
    • Year: 2022

Prof. Jian Zaiyou | Botanical Drug | Best Researcher Award

Posted on by Pencis

Prof. Jian Zaiyou | Botanical Drug | Best Researcher Award

Henan Institute of Science and Technology | China

AUTHOR PROFILE

Scopus

🎓EARLY ACADEMIC PURSUITS 🌱

Born in January 1973 in Huai Bin County, Henan Province, China, you began your academic journey with a keen interest in traditional Chinese medicine. Your pursuit of excellence led you to Beijing University of Chinese Medicine, where you obtained your Ph.D. in 2010. This foundational education equipped you with deep knowledge and expertise in medicinal botany and Chinese medicine, shaping your future academic and professional endeavors.

🏫PROFESSIONAL ENDEAVORS 🌿

Currently, you serve as an Associate Professor at the Henan Institute of Science and Technology, where you teach key subjects such as Chinese Medicine Processing, Chinese Medicine, and Medicinal Botany. Your teaching is enriched by practical applications and extensive research experience, fostering a deeper understanding of traditional Chinese medicinal practices among students.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON BOTANICAL DRUG📚

Your research centers on the cultivation of medicinal plants, quality evaluation of Chinese medicine, and related fields. You have successfully presided over two research projects funded by the Science and Technology Department of Henan Province, which have significantly advanced the regional understanding of medicinal botany. Additionally, your contributions include authoring influential books such as:

  • Chinese Authentic Medicine
  • Wolfberry Practical Production Technology
  • Botany

Your work has provided practical and theoretical frameworks for improving the cultivation and processing of medicinal plants.

📖IMPACT AND INFLUENCE 🌟

With over 20 published scientific papers and 2 invention patents, your scholarly impact extends beyond Henan Province, influencing Chinese medicine practices at both regional and national levels. Your patents demonstrate innovation in the field, highlighting your commitment to improving traditional medicine through modern techniques.

📈ACADEMIC CITES 📝

Your contributions to Chinese medicine and botany have garnered attention in academic circles, with your work frequently cited in journals focused on medicinal botany, traditional medicine quality evaluation, and innovative cultivation techniques. These citations underline the importance of your research in advancing the field.

🚀LEGACY AND FUTURE CONTRIBUTIONS🌍

Your legacy lies in bridging traditional Chinese medicine with modern scientific approaches. By educating future generations and enhancing the quality standards of Chinese medicine, you have created a sustainable foundation for innovation in this field. Future contributions could include exploring global collaborations to integrate traditional Chinese medicine into international therapeutic practices and advancing the commercialization of medicinal botany technologies.

📚HIGHLIGHT 🌟

Through your dedicated teaching, pioneering research, and impactful publications, you have established yourself as a leading figure in the realm of Chinese medicine and medicinal botany. Your work not only preserves the rich traditions of Chinese medicine but also propels it into the future, ensuring its relevance in modern science and healthcare.

🌟CONCLUSION 🌿

Your journey from Huai Bin County to becoming an esteemed Associate Professor and researcher exemplifies dedication to advancing traditional Chinese medicine and medicinal botany. Through impactful teaching, innovative research, and valuable publications, you have significantly contributed to the preservation and modernization of Chinese medicinal practices. Your work has laid a robust foundation for future advancements, ensuring that the rich heritage of Chinese medicine continues to thrive in an evolving global healthcare landscape. As you expand your contributions, your influence will undoubtedly inspire new generations of scholars and practitioners, fostering a lasting legacy in the field.

📊🔬NOTABLE PUBLICATION:
  • Photosynthetic and Chlorophyll Fluorescence Characteristics of Isodon rubescens (Hemsley) H. Hara
    • Authors: Zaiyou, J.; Xiuren, Z.; Jing, T.
    • Journal: Scientific Reports
    • Year: 2020

 

  • Evaluate the Photosynthesis and Chlorophyll Fluorescence of Epimedium brevicornu Maxim
    • Authors: Zaiyou, J.; Xiaomin, T.; Hongsheng, W.; Guifang, X.
    • Journal: Scientific Reports
    • Year: 2022

 

  • Study on the Cause of Peeling and Withering in Isodon rubescens Stems in Winter
    • Authors: Zaiyou, J.; Xiaomin, T.; Lei, D.
    • Journal: Journal of King Saud University – Science
    • Year: 2022

 

  • Analysis on the Quality of Epimedii folium Originating from Cultivated Epimedium pubescens Maxim
    • Authors: Zaiyou, J.; Guifang, X.; Jing, T.
    • Journal: Bangladesh Journal of Botany
    • Year: 2021

 

  • Photosynthesis Capacity and Chlorophyll Fluorescence Characteristics of the Isodon rubescens (Hemsley) H. Hara Stem
    • Authors: Zaiyou, J.I.A.N.; Susu, J.I.A.N.; Xiaomin, T.A.N.G.; Genhai, H.U.
    • Journal: Scientific Reports
    • Year: 2024

Dr. Wenjin Wang | Targeted Cancer Therapy | Young Scientist Award

Posted on by Pencis

Dr. Wenjin Wang | Targeted Cancer Therapy | Young Scientist Award

The Chinese University of Hong Kong | China

Author Profile

Scopus

Dr. Wenjin Wang 🌟🔬

Postdoctoral Researcher | Tumor Photodynamic Therapy Expert | Biomolecular Phase Separation Investigator

Research Interests

  1. Tumor Photodynamic Therapy (PDT) 💡🎯
    • Design and synthesis of novel photosensitizers for PDT.
    • Development of tumor-targeted PDT using tumor-responsive AIE (Aggregation-Induced Emission) photosensitizers.
  2. Regulation of Biomolecular Phase Separation 🧬⚛️
    • Investigation into the phase separation behaviors of biomolecules like proteins and nucleic acids.
    • Modulation of these processes with chemical molecules to enhance understanding of intracellular organization and function.

Professional Experience

  • Postdoctoral Researcher 🏢
    The Chinese University of Hong Kong, Shenzhen (07/2022–Present)

    • Research on bioapplications of AIE materials under Prof. Ben Zhong Tang.
  • Biochemical Engineer 🧪
    Shenzhen BGI Research Institute (10/2017–09/2018)

    • Designed and optimized unnatural nucleotides for sequencing applications.
  • Laboratory Assistant 🔬
    Peking University Shenzhen Graduate School (11/2016–10/2017)

    • Focused on unnatural amino acids and asymmetric carbene O-H bond insertion catalysis by myoglobin proteins.
  • Research Associate 💊
    Tianjin Institute of Pharmaceutical Research (08/2014–11/2016)

    • Developed new hypoglycemic drugs through innovative designs and research.

Education

  • Ph.D. in Chemical Biology 🧫
    Sun Yat-Sen University (09/2018–06/2022)

    • Thesis: Antitumor mechanisms of metal complexes and their regulation on biomolecular phase separation behavior.
  • M.S. in Pharmacy 💊
    Tianjin Medical University (09/2012–06/2015)

    • Research: Development of SGLT2 inhibitors and hypoglycemic activity evaluation.
  • B.S. in Pharmacy 🏥
    Tianjin Medical University (09/2008–06/2012)

Grants and Funding 💰📚

  1. National Natural Science Foundation of China
    • Ruthenium Complexes and Lipid Phase Separation in Antitumor Research (2024–2026, RMB 300K, Principal Investigator).
  2. China Postdoctoral Science Foundation
    • GGT-Activated AIE Photosensitizers for Tumor Photodynamic Therapy (2022–2025, RMB 80K, Principal Investigator).
  3. Shenzhen Medical Research Fund
    • Manipulable Aggregation of AIE Photosensitizers for Enhanced Tumor PDT (2025–2027, RMB 800K, Principal Investigator).
  4. National Natural Science Foundation of China
    • Phase Separation Mechanism of Antitumor Phosphor Metal Complexes (2022–2025, RMB 630K, Major Participant).
  5. Yunnan Province Science and Technology Plan
    • Aggregate Induced Luminescence in Biomass Resources (2024–2026, RMB 2000K, Major Participant).

Awards and Honors 🏆✨

  • Excellent Postdoctoral Doctor (Shenzhen, 12/2023).
  • National Scholarship for Doctoral Students (12/2021).
  • “Fran” Excellent Thesis Scholarship (Second Class, Sun Yat-sen University, 11/2021).
  • Excellent Wall Poster Award (32nd Academic Annual Meeting, Chinese Chemical Society, 04/2021).

Key Contributions 📈

Dr. Wang’s groundbreaking research combines innovative photodynamic therapies and the manipulation of biomolecular phase separation, driving advancements in cancer treatment and molecular biology.

📊🔬NOTABLE PUBLICATION:
  • Title: Multi-Stimuli-Responsive and Cell Membrane Camouflaged Aggregation-Induced Emission Nanogels for Precise Chemo-photothermal Synergistic Therapy of Tumors
    • Authors: Zhang, L.; Wang, Z.; Zhang, R.; … Zhao, Z.; Tang, B.Z.
    • Journal: ACS Nano
    • Year: 2023

 

  • Title: Multi-site isomerization of synergistically regulated stimuli-responsive AIE materials toward multi-level decryption
    • Authors: Zhong, W.; Zhang, J.; Lin, Y.; … Cai, X.-M.; Tang, B.Z.
    • Journal: Chemical Science
    • Year: 2024

 

  • Title: Chromene-based BioAIEgens: ‘in-water’ synthesis, regiostructure-dependent fluorescence and ER-specific imaging
    • Authors: Cai, X.-M.; Lin, Y.; Zhang, J.; … Zhao, Z.; Tang, B.Z.
    • Journal: National Science Review
    • Year: 2023

 

  • Title: Natural Acceptor of Coumarin-Isomerized Red-Emissive BioAIEgen for Monitoring Cu²⁺ Concentration in Live Cells via FLIM
    • Authors: Cai, X.-M.; Li, S.; Wang, W.-J.; … Zhao, Z.; Tang, B.Z.
    • Journal: Advanced Science
    • Year: 2024

 

  • Title: Room Temperature Phosphorescent Nanofiber Membranes by Bio-Fermentation
    • Authors: Nie, X.; Gong, J.; Ding, Z.; … Qiu, Z.; Tang, B.Z.
    • Journal: Advanced Science
    • Year: 2024

Mr. Wenhui Wang | Macrophage | Best Researcher Award

Posted on by Pencis

Mr. Wenhui Wang | Macrophage | Best Researcher Award

The First Affiliated Hospital of Dalian Medical University | China

AUTHOR PROFILE

Scopus

📚EARLY ACADEMIC PURSUITS 

Wenhui wang’s academic journey began with a strong foundation in medical imaging, completing a bachelor’s degree in medical imaging at shanxi medical university fenyang college in 2021. He then pursued a master’s in radiological imaging at shanxi medical university, graduating in july 2024. His dedication to advancing medical imaging continues with his current ph.d. Study in imaging medicine and nuclear medicine at dalian medical university, where he is engaged in cutting-edge research.

🧑‍🔬PROFESSIONAL ENDEAVORS 

Wenhui wang has embarked on a promising research career in the field of medical imaging and radiological science, particularly focused on macrophage tracking, stem cell imaging, and the development of advanced imaging probes. He is a principal investigator for several significant research projects in shanxi, including the development of new contrast agents for dynamic studies and the study of molecular imaging in the diagnosis and assessment of osteogenic and chondrogenic tumors like osteosarcoma and chondrosarcoma.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MACROPHAGE 

His research interests span a range of innovative topics, including macrophage tracking imaging, stem cell repair of osseocartilaginous defects, and the application of imaging for the diagnosis of traumatic and tumorous lesions in bones and joints. He is particularly interested in understanding the role of nano-molecular probes and developing novel imaging agents to improve diagnosis and treatment predictions in oncology and infectious diseases.

IMPACT AND INFLUENCE 🌍

Wenhui wang’s research has the potential to significantly impact the fields of radiological imaging, medical diagnostics, and stem cell research. His work in the development of nano-probes for molecular imaging could lead to advancements in the early diagnosis of cancer and improve the understanding of tumor behavior. Additionally, his study of stem cell therapy and cartilage repair could open new avenues in regenerative medicine.

AWARDS AND HONORS 🏅

Wang has received several academic awards for his exceptional performance and contributions to the field, including the master’s national scholarship, multiple university-level prizes, and recognition in competitions like the zhongqing cup national college student mathematical modeling competition. These awards reflect his outstanding academic achievements and dedication to excellence.

ACADEMIC CITES AND RECOGNITION 📜

Wang’s research has garnered increasing attention in the field of medical imaging, particularly through his pioneering studies in the application of technologies in tumor diagnosis and stem cell repair. His work is expected to contribute to future clinical practices and influence future research directions in the medical imaging community.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Wenhui wang is set to leave a lasting legacy in the fields of radiological imaging and stem cell therapy. His innovative research on advanced imaging agents and stem cell interventions could not only improve the diagnosis and treatment of cancer and bone diseases but also pave the way for new clinical applications in regenerative medicine. His future work has the potential to transform the way we approach medical imaging and treatment predictions.

🔗 CONCLUSION

Wenhui Wang is an emerging talent in the fields of medical imaging and nuclear medicine, with a strong foundation in radiological imaging and a forward-thinking research agenda. His work, focusing on macrophage tracking, stem cell therapy, and the development of novel imaging probes, positions him at the forefront of medical imaging advancements. Through his groundbreaking research, he has already demonstrated significant contributions to the understanding and treatment of osteogenic and chondrogenic tumors, as well as the enhancement of cartilage repair techniques.

📊🔬NOTABLE PUBLICATION:
  • Prognostic Factors and Surgical Impact of Non-metastatic Conventional Chondrosarcoma of the Extremities
    • Authors: Wang, W., Zhen, J.
    • Journal: Orthopaedic Surgery
    • Year: 2023

 

  • MRI Radiomics-based Evaluation of Tuberculous and Brucella Spondylitis
    • Authors: Wang, W., Fan, Z., Zhen, J.
    • Journal: Journal of International Medical Research
    • Year: 2023

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Posted on by Pencis

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Yueyang Central Hospital | China

AUTHOR PROFILE

ORCID ID

📚EARLY ACADEMIC PURSUITS 

ZENG QINGJUN completed his Master’s degree at Xiangya Medical College, Central South University, in 2010. This prestigious institution provided a strong foundation in medical education, equipping him with the skills and knowledge necessary for his future in the field of gastrointestinal surgery. His academic training allowed him to develop expertise in complex surgical techniques, laying the groundwork for his career as a clinical specialist in surgery.

⚕️PROFESSIONAL ENDEAVORS 

Since July 2010, ZENG QINGJUN has been working in the field of gastrointestinal surgery, focusing on laparoscopic techniques for treating gastric and colorectal cancers. As a chief physician, he plays a pivotal role in leading surgical teams, performing high-risk surgeries, and making critical decisions for patient care. His clinical expertise and skillful handling of over 200 laparoscopic gastric cancer surgeries and 400 laparoscopic colorectal cancer surgeries are testaments to his proficiency in minimally invasive surgical methods. His surgical outcomes have contributed significantly to improving the quality of life for cancer patients and are recognized within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON GASTROINTESTINAL TUMORS

Dr. ZENG has dedicated much of his professional life to the development and refinement of laparoscopic surgical techniques in the treatment of gastrointestinal cancers. His research is heavily focused on advancing minimally invasive surgery, particularly in the areas of gastric cancer and colorectal cancer. Through clinical trials and innovative methodologies, he has been involved in optimizing surgical procedures to ensure better postoperative recovery, reduced complications, and more efficient treatment pathways for cancer patients.

🌍IMPACT AND INFLUENCE 

Dr. ZENG QINGJUN has made an immense impact on the practice of gastrointestinal surgery in China, particularly in the realm of laparoscopic surgery. His innovative approaches and commitment to cutting-edge techniques have influenced both local and national surgical practices. His contribution to gastric and colorectal cancer surgery has improved patient outcomes and has set new standards in the field. As a chief physician, he mentors younger surgeons and shares his expertise, ensuring the continued progress of surgical techniques.

📑ACADEMIC CITATIONS 

While detailed citation metrics are not provided, Dr. ZENG’s extensive clinical experience and research endeavors have led to his recognition in academic circles. His focus on laparoscopic techniques and cancer surgery continues to influence current and future generations of surgeons and researchers in the field. His work, particularly in gastric and colorectal cancer, has made notable contributions to medical literature and has been referenced in various academic and clinical studies.

🌱LEGACY AND FUTURE CONTRIBUTIONS 

Dr. ZENG QINGJUN’s career reflects a legacy of excellence in surgical practice and medical innovation. His pioneering work in laparoscopic surgery and cancer treatment has already set the stage for future breakthroughs in the field of gastrointestinal oncology. Looking forward, he is likely to contribute even more significantly to surgical research, possibly expanding his focus to robot-assisted surgeries, postoperative care advancements, and the integration of AI in surgical planning. His mentorship, both locally and nationally, will shape the future of surgical education and the next generation of gastrointestinal surgeons.

💼LEADERSHIP IN SURGICAL PRACTICE 

Dr. ZENG continues to hold a significant leadership role in the surgical department at his medical institution. His capacity as chief physician enables him to make high-level decisions in clinical practice, direct surgical teams, and implement best practice guidelines. His strategic leadership in gastrointestinal surgery helps to establish protocols for laparoscopic surgeries, improving surgical outcomes, and pushing the boundaries of traditional approaches.

🔗 CONCLUSION

Dr. Zeng Qingjun is a distinguished gastrointestinal surgeon whose work has significantly advanced the field of laparoscopic surgery for gastric and colorectal cancers. With over a decade of experience and hundreds of successful surgeries, his contributions have set new standards in minimally invasive surgical techniques, improving patient outcomes and recovery times. Through his leadership as chief physician, he has not only influenced clinical practices but has also become a mentor to aspiring surgeons, ensuring the continuity of high-quality surgical education.

📊🔬NOTABLE PUBLICATION:
  • 1. Title: Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway
    Authors: Qingjun Zeng, Sanjun Zhang, Linfang He, Qingyan Fu, Li Liao, Linjie Chen, Xiang Ding
    Journal: Cancer Biotherapy and Radiopharmaceuticals
    Year: 2023

    2. Title: Targeting of MAD2L1 by miR‐515‐5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells
    Authors: Xiang Ding, Qingyan Fu, Weixing Chen, Linjie Chen, Qingjun Zeng, Sanjun Zhang, Linfang He
    Journal: Cell Biology International
    Year: 2022

Prof. Ming-Yow Hung | Cardio-Oncology | Best Researcher Award

Posted on by Pencis

Prof. Ming-Yow Hung | Cardio-Oncology | Best Researcher Award

Taipei Medical University | Taiwan

Author Profile

Scopus

ORCID ID

Biography: Prof. Ming-Yow Hung, MD, PhD 🌟💖🩺

Name: Prof. Ming-Yow Hung
Citizenship: Taiwanese

🎓 Education:

  • Medical Degree: School of Medicine, College of Medicine, Chang Gung University (1989–1995).
  • PhD: Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine (2007–2017).

🎖 Military Service:

  • Lieutenant General Physician, Navy, Taiwan, Republic of China (1996–1998).

💼 Professional Roles:

  • Attending Cardiologist: Division of Cardiology, Shuang Ho Hospital, Taipei Medical University (2008–present).
  • Professor of Medicine: Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University (since 2022).

🏅 Board Certifications:

  • Internal Medicine (2001).
  • Adult Cardiology (2004).

🔬 Research Interests:

  • Interventional Cardiology
  • Echocardiography
  • Basic Cardiovascular Science

📜 Editorial Contributions:

  • Editorial Board Member:

    • Enliven: Clinical Cardiology and Research (2015–present).
    • Journal of Epidemiological Research (2015–present).
    • SM Vascular Medicine (2015–present).

  • Guest Editor:

    • Journal of Interventional Cardiology (2019–2020).
    • Oxidative Medicine and Cellular Longevity (2023).
    • Frontiers in Cardiovascular Medicine (2023).
    • Life (2023).

🎯 Research Projects:

  1. Investigating macrophage polarization in coronary artery spasm using CRISPR core facilities (2020–2021).
  2. Mechanisms of Garcinol as α-7nAChRs Inhibitor in cardiac damage (2021–2022).
  3. LPCAT4/GDE7 axis as therapeutic targets in coronary artery spasm (2022–2023).
  4. SCAP/SREBPs signaling in lipoprotein(a)-induced macrophage polarization (2023–2026).

🌟 Professional Affiliations:

  • Fellow, American Heart Association (2013–present).
  • Fellow, American College of Cardiology (2014–present).
  • Member of multiple Taiwanese and international cardiology societies.

🏆 Honors and Awards:

  • Clinical Medicine Research Award, Taipei Medical University (2014, 2015).
  • Recognition for outstanding contributions to cardiovascular research and patient care.

Prof. Hung is renowned for his dedication to advancing cardiovascular science, particularly in coronary artery spasm and interventional cardiology. 🌍❤️

🔗 CONCLUSION

Prof. Ming-Yow Hung is a distinguished cardiologist and academic leader, whose expertise in interventional cardiology, echocardiography, and cardiovascular science has earned him national and international recognition. As a Full Professor at Taipei Medical University and a Fellow of esteemed cardiology organizations, he has made significant contributions to both clinical practice and research.

📊🔬NOTABLE PUBLICATION:
  • Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α 7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm
    • Authors: Lin, Y.-K.; Yeh, C.-T.; Kuo, K.-T.; Hu, P.; Hung, M.-Y.
    • Journal: Oxidative Medicine and Cellular Longevity
    • Year: 2022

 

  • The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review
    • Authors: Karimabad, M.N.; Kounis, N.G.; Hassanshahi, G.; Hung, M.-Y.; Nadimi, A.E.
    • Journal: Vaccines
    • Year: 2021

 

  • The Effect of Long COVID-19 Infection and Vaccination on Male Fertility: A Narrative Review
    • Authors: Pourmasumi, S.; Nazari, A.; Ahmadi, Z.; Altay, S.; Kounis, N.G.
    • Journal: Vaccines
    • Year: 2022

 

  • “When,” “Where,” and “How” of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review
    • Authors: Kounis, N.G.; Gogos, C.; de Gregorio, C.; Velissaris, D.; Koniar, I.
    • Journal: Balkan Medical Journal
    • Year: 2024

 

  • Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review
    • Authors: Hung, M.-J.; Yeh, C.-T.; Kounis, N.G.; Hu, P.; Hung, M.-Y.
    • Journal: International Journal of Molecular Sciences
    • Year: 2023

Assist. Prof. Dr. Ting Zhu | Pharmaco-Oncology | Best Researcher Award

Posted on by Pencis

Assist. Prof. Dr. Ting Zhu | Pharmaco-Oncology | Best Researcher Award

Qingdao University | China

AUTHOR PROFILE

Scopus

ORCID ID

🧩 EARLY ACADEMIC PURSUITS

Dr. Ting Zhu’s academic journey began with a strong foundation in pharmacology and related biomedical sciences. Her early education and research laid the groundwork for her focus on cardiovascular and cerebrovascular pharmacology. This formative phase shaped her expertise in the integration of traditional Chinese medicine (TCM) with modern pharmacological principles.

💼 PROFESSIONAL ENDEAVORS

As a Master’s Supervisor at Qingdao Medical College, Qingdao University, Dr. Zhu has become a pivotal figure in guiding students and contributing to cutting-edge research. Her dedication to academic excellence is reflected in her active leadership in national and provincial projects, fostering innovation and exploration in pharmacological sciences.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACO-ONCOLOGY

Dr. Zhu’s research delves into the regulation of mitochondria by TCM and its main components for the prevention and treatment of nerve injury. Her groundbreaking work has revealed the preventive effects and molecular mechanisms of these compounds on ischemic stroke, bridging traditional medicine with modern therapeutic approaches.

🌟 IMPACT AND INFLUENCE

Dr. Zhu’s research outputs, including more than 20 academic papers published in high-level international journals, have significantly advanced the understanding of ischemic stroke and pharmacological neuroprotection. Her work has gained recognition within the academic community for its innovation and practical applications.

📖 ACADEMIC CITATIONS

With a robust publication record, Dr. Zhu’s studies have garnered extensive citations in the global scientific community, reflecting the influence and relevance of her research. Her findings continue to inform and inspire further investigations in pharmacology and TCM integration.

🎯 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Zhu’s ongoing dedication to exploring molecular mechanisms and drug development promises a lasting impact on the field of pharmacology. Her leadership in bridging traditional and modern medicinal practices positions her as a key figure in shaping future therapeutic strategies for nerve injury and cardiovascular diseases.

🏅 OTHER SIGNIFICANT ACHIEVEMENTS

  • National and Provincial Projects: Successfully presided over three major scientific research initiatives.
  • Mentorship: Plays a crucial role in cultivating the next generation of researchers in pharmacology and TCM.
  • Cross-disciplinary Innovation: Pioneering efforts in integrating mitochondrial regulation with TCM for innovative therapeutic approaches.

Dr. Ting Zhu’s remarkable contributions underscore her commitment to advancing science and medicine through an interdisciplinary lens, promising a transformative impact on global healthcare.

🔗 CONCLUSION

Dr. Ting Zhu stands at the forefront of modern pharmacology, seamlessly integrating traditional Chinese medicine with advanced molecular research to address pressing health challenges like ischemic stroke and nerve injury. Her dedication to mentorship, impactful research, and innovative drug development underscores her significant contributions to both academic and clinical fields. As she continues to lead groundbreaking projects and inspire future generations, Dr. Zhu’s work promises to shape the future of pharmacology and redefine the role of traditional medicine in modern therapeutic practices. Her legacy is one of innovation, excellence, and transformative impact on global health.

 

📊🔬NOTABLE PUBLICATION:
  • Pharmacological Properties and Mechanisms of Notoginsenoside R1 in Ischemia-Reperfusion Injury
    • Authors: Zhu, T., Wan, Q.
    • Journal: Chinese Journal of Traumatology – English Edition
    • Year: 2023

 

  • Notoginseng Leaf Triterpenes Ameliorates Mitochondrial Oxidative Injury via the NAMPT-SIRT1/2/3 Signaling Pathways in Cerebral Ischemic Model Rats
    • Authors: Xie, W., Zhu, T., Zhou, P., Sun, G., Sun, X.
    • Journal: Journal of Ginseng Research
    • Year: 2023

 

  • DL-3-n-Butylphthalide Attenuates Cerebral Ischemia/Reperfusion Injury in Mice Through AMPK-Mediated Mitochondrial Fusion
    • Authors: Zhu, T., Dong, S., Qin, N., Shi, L., Wan, Q.
    • Journal: Frontiers in Pharmacology
    • Year: 2024

 

  • Effect of Salidroside on Neuroprotection and Psychiatric Sequelae During the COVID-19 Pandemic: A Review
    • Authors: Zhu, T., Liu, H., Gao, S., Chen, S., Xie, W.
    • Journal: Biomedicine and Pharmacotherapy
    • Year: 2024

 

  • Mechanism of Efferocytosis in Determining Ischemic Stroke Resolution—Diving into Microglia/Macrophage Functions and Therapeutic Modality
    • Authors: Xie, X.-D., Dong, S.-S., Liu, R.-J., Shi, L.-L., Zhu, T.
    • Journal: Molecular Neurobiology
    • Year: 2024

Dr. Ke Zhao | Orthopedics| Best Researcher Award

Posted on by Pencis

Dr. Ke Zhao | Orthopedics | Best Researcher Award

Wangjing Hospital of China Academy of Chinese Medical Sciences | China

Author Profile

Scopus

🩺 Dr. Ke Zhao: Resident Doctor in Orthopedics

🎓 Educational Background

  • Bachelor’s Degree (2015–2020): Hubei University of Traditional Chinese Medicine
  • Master’s Degree (2023): Hubei University of Traditional Chinese Medicine

🏆 Awards & Achievements

  • 🥉 Third Prize: Jiangsu Province “Olympic Cup” Chemistry Competition (2020)
  • 🎤 Third Prize: Hubei Province “Baisheng Lecture Theatre” Provincial Hosts (2021)
  • 🎓 National Scholarship for Postgraduate Students (2022)
  • 🌟 Hubei Province All-Round Good Student Award (2022)
  • 🎖️ Hubei Province Outstanding Graduates Award (2023)

🧑‍🔬 Research Interests

  • Intervertebral Disc Disorders
  • Osteoporosis
  • Osteonecrosis of the Femoral Head

💼 Professional Skills

  • Advanced Office Suite Proficiency
  • WeMedia Content Creation
  • Academic Research in Osteology and Traumatology

🌍 Languages

  • Proficient in English (CET-6 Certified)

🧑‍🏫 Academic Mentorship

Mentored by Dr. Li Guo Zhu, an expert in Osteology and Traumatology.

Ke Zhao is a dedicated medical professional focused on orthopaedic research and clinical excellence. With strong expertise in degenerative bone conditions and a commitment to advancing healthcare, he exemplifies the values of precision and empathy in medical practice.

✨Conclusion:

Dr. Ke Zhao is a skilled and compassionate orthopedic resident dedicated to advancing medical science and improving patient care. With a strong academic foundation, notable achievements, and a focus on conditions such as intervertebral disc disorders, osteoporosis, and osteonecrosis of the femoral head, Dr. Zhao continues to make meaningful contributions to the field of osteology and traumatology. Guided by excellence and innovation, he exemplifies a commitment to both clinical practice and research, paving the way for a promising career in orthopaedic medicine.

 

📊🔬NOTABLE PUBLICATION:
1. Lateral Locking Plate Plus Antero-Posterior Lag Screws Techniques for the Management of Posterolateral Tibial Plateau Fracture: Preliminary Clinical Results and Biomechanical Study

Authors: Gao, W., Qi, X., Zhao, K., Liu, P., Fu, D.
Journal: Archives of Orthopaedic and Trauma Surgery
Year: 2023

2. Multifunctional Gold Nanoparticles for Osteoporosis: Synthesis, Mechanism and Therapeutic Applications

Authors: Gao, W., Liang, C., Zhao, K., Hou, M., Wen, Y.
Journal: Journal of Translational Medicine
Year: 2023

3. Percutaneous Endoscopic Lumbar Discectomy for the Treatment of Recurrent Lumbar Disc Herniation: A Meta-analysis

Authors: Zhao, K., Li, L.-D., Li, T.-T., Xiong, Y.
Journal: BioMed Research International
Year: 2022

4. When Is the Optimum Time for the Initiation of Early Rehabilitative Exercise on the Postoperative Functional Recovery of Peri-Ankle Fractures? A Network Meta-Analysis

Authors: Zhao, K., Dong, S., Wang, W.
Journal: Frontiers in Surgery
Year: 2022

Dr. Na Wang | Chemotherapy | Best Researcher Award

Posted on by Pencis

Dr. Na Wang | Chemotherapy | Best Researcher Award

First Affiliated Hospital of Xi’an Jiaotong University | China

AUTHOR PROFILE

Scopus

📘 DR. NA WANG, DEPARTMENT OF RESPIRATORY AND CRITICAL CARE MEDICINE, FIRST AFFILIATED HOSPITAL OF XI’AN JIAOTONG UNIVERSITY

🏫 EARLY ACADEMIC PURSUITS

Dr. Na Wang embarked on a distinguished academic journey, laying a strong foundation in respiratory medicine and critical care. She pursued her medical degree with a focus on respiratory health, demonstrating exceptional dedication and a commitment to addressing complex medical challenges. Her postgraduate studies were marked by advanced training in pulmonology, where she honed her expertise in the diagnosis and management of respiratory diseases.

🏥 PROFESSIONAL ENDEAVORS

Currently serving at the First Affiliated Hospital of Xi’an Jiaotong University, Dr. Wang plays a pivotal role in the Department of Respiratory and Critical Care Medicine. She has contributed significantly to clinical care, focusing on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) and the broader spectrum of critical care management. Dr. Wang is recognized for her ability to translate complex clinical scenarios into innovative therapeutic strategies, improving patient outcomes.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMOTHERAPY

Dr. Wang’s research is centered on Chronic Obstructive Pulmonary Disease (COPD), particularly its acute exacerbations, which are leading causes of hospitalization and mortality worldwide. Her studies delve into:

  • The pathophysiological mechanisms underlying AECOPD.
  • Biomarker identification for early diagnosis and prognosis.
  • Innovative therapeutic approaches, including pharmacological and non-pharmacological strategies.
    Her work bridges clinical insights with translational research, contributing to the development of effective treatment modalities.

🌟 IMPACT AND INFLUENCE

Dr. Wang’s research has had a profound impact on the respiratory medicine field, especially in China. Her findings have been instrumental in shaping clinical guidelines for AECOPD management, benefiting countless patients. She is a sought-after speaker at national and international conferences, sharing her expertise on managing critical respiratory conditions.

📚 ACADEMIC CITES

With a growing body of published works, Dr. Wang has contributed extensively to peer-reviewed journals. Her articles are widely cited, reflecting the significance of her research. She continues to advance the field through collaborations with leading respiratory medicine experts and research teams globally.

🌏 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Na Wang is poised to leave an enduring legacy in respiratory and critical care medicine. Her commitment to:

  1. Advancing knowledge in AECOPD management.
  2. Mentoring future clinicians and researchers.
  3. Pioneering innovative therapeutic approaches.
    ensures that her influence will resonate for years to come. Her future contributions are expected to address emerging challenges in respiratory health and critical care, particularly in aging populations.

🛠 OTHER IMPORTANT TOPICS

💡 MULTIDISCIPLINARY APPROACH

Dr. Wang advocates for collaboration across specialties to improve patient care and advance research. Her work integrates insights from immunology, pharmacology, and critical care practices.

🎓 EDUCATION AND TRAINING INITIATIVES

Dr. Wang is actively involved in teaching and training, emphasizing evidence-based practices to cultivate the next generation of respiratory care professionals. He exemplifies excellence in respiratory and critical care medicine, with a career characterized by impactful research, clinical leadership, and an enduring commitment to improving patient outcomes.

✨CONCLUSION:

Dr. Na Wang stands as a beacon of excellence in Respiratory and Critical Care Medicine, particularly in the management and research of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Her journey from a dedicated academic to an influential clinician and researcher reflects her unwavering commitment to advancing healthcare. Through groundbreaking research, impactful teaching, and exemplary clinical practice, Dr. Wang has significantly shaped the field, improving the lives of countless patients and setting a high standard for future contributions.

📊🔬NOTABLE PUBLICATION:
  • The association between chronic obstructive pulmonary disease and autoimmune diseases: a bidirectional Mendelian randomization study
    • Authors: Yu, X., Cheng, X., Lv, L., … Hu, T., Shi, Z.
    • Journal: Frontiers in Medicine
    • Year: 2024
  • A left pulmonary artery sling with left bronchiectasis in an adult patient: A case report and review of literature
    • Authors: Lv, L., Cheng, X., Yu, X., … Liu, J., Shi, Z.
    • Journal: Respirology Case Reports
    • Year: 2023
  • Prolonged elevated heart rate is associated with adverse outcome in severe pulmonary embolism: A retrospective study
    • Authors: Wang, G., Liu, T., Ji, W., … Hu, T., Shi, Z.
    • Journal: International Journal of Cardiology
    • Year: 2024
  • Association between prognostic nutritional index and mortality risk in patients with community-acquired pneumonia: a retrospective study
    • Authors: Wang, G., Wang, N., Liu, T., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024
  • Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients
    • Authors: Wang, N., Li, M., Wang, G., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024